Novel vaccine approaches for n. Meningitidis disease

Ended Project Grant Awarded Last action

Award ID
R01AI046464
Recipient
Awarding agency
Obligated
$11,741,685

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $11,367,955.00 Federal
  • $373,730.00 Non-federal
Place of performance
California, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $37,373 $0
Amendment $37,373 $0
Amendment $336,357 $0
Amendment $336,357 $0
Amendment $336,357 $0
Amendment $373,730 $0
Amendment $373,730 $0
Amendment $373,730 $0
Amendment $373,730 $0
Amendment $373,730 $0
Amendment $373,730 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $373,730 $0
Amendment $373,730 $373,730
Amendment $18,683 $0
Amendment -$18,683 $0
Amendment $18,683 $18,683
Amendment -$18,683 -$18,683
Amendment -$512,189 $0
Amendment $292,679 $0
Amendment $654,028 $0
Amendment $0 $0
Amendment Meningococcal and gonococcal vaccine to prevent invasive disease and carriage $0 $0
Amendment $641,748 $0
Amendment $641,748 $0
Amendment $641,748 $0
Amendment $641,748 $0
Amendment $672,223 $0
Amendment Meningococcal serogroup b vaccine to prevent invasive disease and carriage $550,570 $0
Amendment $631,670 $0
Amendment $651,283 $0
Amendment $604,832 $0
Amendment Novel vaccine strategies for prevention of n. Meningitidis group b disease $587,866 $0
Original award $594,344 $0
Show all 37

Quick answers

Who received award R01AI046464?

R01AI046464 was awarded to Omvax, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 1999.

How much is award R01AI046464 worth?

$11,741,685 has been obligated on R01AI046464: $11,367,955 in federal funding and $373,730 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award